Rang	Name	Position
1	Mr. Sean P. Nolan	CEO & Chairman
2	Dr. Sukumar Nagendran M.D.	President, Head of Research & Development and Director
3	Mr. Kamran Alam CPA, M.B.A.	CFO & Corporate Secretary
4	Hayleigh Collins	Director of Corporate Communications & Investor Relations
5	Mr. Michael B. Johannesen	Chief Legal Officer & Corporate Secretary
6	Mr. Frederick Porter Ph.D.	Chief of Staff & Technical Operations Officer
7	Ms. Emily McGinnis M.P.H.	Chief Patient & External Affairs Officer
8	Mr. Sean McAuliffe	Chief Business Officer
9	Dr. Steven Gray Ph.D.	Chief Scientific Advisor of UT Southwestern Gene Therapy Program
10	Berge Minassian M.D.	Chief Medical Advisor of UT Southwestern Gene Therapy Program

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	RA Capital Management, LLC	7,25%	0,12 Mrd. USD
2	The Goldman Sachs Group Inc	6,89%	0,11 Mrd. USD
3	venBio Select Advisor LLC	6,68%	0,11 Mrd. USD
4	BlackRock Inc	5,65%	0,09 Mrd. USD
5	Vestal Point Capital LP	5,54%	0,09 Mrd. USD
6	Morgan Stanley - Brokerage Accounts	5,53%	0,09 Mrd. USD
7	FMR Inc	4,41%	0,07 Mrd. USD
8	RTW INVESTMENTS, LLC	4,21%	0,07 Mrd. USD
9	State Street Corp	3,45%	0,06 Mrd. USD
10	Vanguard Capital Management, LLC	3,15%	0,05 Mrd. USD
11	Octagon Capital Advisors LP	2,98%	0,05 Mrd. USD
12	Siren, L.L.C.	2,72%	0,04 Mrd. USD
13	Polar Capital Holdings PLC	1,74%	0,03 Mrd. USD
14	Geode Capital Management, LLC	1,70%	0,03 Mrd. USD
15	MPM Oncology Impact Management LP	1,39%	0,02 Mrd. USD
16	D. E. Shaw & Co LP	1,35%	0,02 Mrd. USD
17	Baker Bros Advisors LP	1,23%	0,02 Mrd. USD
18	Wellington Management Company LLP	1,22%	0,02 Mrd. USD
19	Casdin Capital, LLC	1,00%	0,02 Mrd. USD
20	ADAR1 Capital Management LLC	0,92%	0,02 Mrd. USD